Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · IEX Real-Time Price · USD
+0.27 (0.63%)
At close: Jun 21, 2024, 4:00 PM
-1.30 (-3.03%)
After-hours: Jun 21, 2024, 7:32 PM EDT

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $770.01M in the twelve months ending March 31, 2024, down -3.11% year-over-year. Revenue in the quarter ending March 31, 2024 was $191.67M with 13.16% year-over-year growth. In the year 2023, Tandem Diabetes Care had annual revenue of $747.72M, a decrease of -6.68%.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
2.77B USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 2023747.72M-53.50M-6.68%
Dec 31, 2022801.22M98.42M14.00%
Dec 31, 2021702.80M203.97M40.89%
Dec 31, 2020498.83M136.53M37.68%
Dec 31, 2019362.31M178.44M97.05%
Dec 31, 2018183.87M76.27M70.88%
Dec 31, 2017107.60M23.35M27.72%
Dec 31, 201684.25M11.40M15.65%
Dec 31, 201572.85M23.13M46.51%
Dec 31, 201449.72M20.72M71.41%
Dec 31, 201329.01M26.53M1,072.00%
Dec 31, 20122.48M--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 4.78B
ICU Medical 2.26B
PTC Therapeutics 927.56M
GoodRx Holdings 764.16M
TG Therapeutics 289.33M
MorphoSys AG 264.75M
SpringWorks Therapeutics 26.45M
IDEAYA Biosciences 15.50M
Revenue Rankings